Beli E, Yan Y, Moldovan L, Lydic T, Krishman P, Tersey S
NPJ Metab Health Dis. 2025; 3(1):3.
PMID: 39911696
PMC: 11790504.
DOI: 10.1038/s44324-024-00039-w.
Khalafi M, Rosenkranz S, Ghasemi F, Kheradmand S, Habibi Maleki A, Korivi M
Nutr Metab (Lond). 2025; 22(1):1.
PMID: 39762987
PMC: 11706068.
DOI: 10.1186/s12986-024-00885-x.
Chen Y, Tsai H, Tu Y, Chen L
BMC Med. 2024; 22(1):529.
PMID: 39533312
PMC: 11559166.
DOI: 10.1186/s12916-024-03716-1.
Singh A, Anjum B, Naz Q, Raza S, Sinha R, Ahmad M
Hepatoma Res. 2024; .
PMID: 39525867
PMC: 7616786.
DOI: 10.20517/2394-5079.2024.88.
Feng R, Yang W, Feng W, Huang X, Cen M, Peng G
Gut Microbes. 2024; 16(1):2390164.
PMID: 39154362
PMC: 11332628.
DOI: 10.1080/19490976.2024.2390164.
Lifestyle intervention for metabolic dysfunction-associated fatty liver disease: a 24-h integrated behavior perspective.
Keating S, Chawla Y, De A, George E
Hepatol Int. 2024; 18(Suppl 2):959-976.
PMID: 38717691
PMC: 11450077.
DOI: 10.1007/s12072-024-10663-9.
Time-Restricted Feeding Attenuates Metabolic Dysfunction-Associated Steatohepatitis and Hepatocellular Carcinoma in Obese Male Mice.
Das M, Kumar D, Sauceda C, Oberg A, Ellies L, Zeng L
Cancers (Basel). 2024; 16(8).
PMID: 38672595
PMC: 11048121.
DOI: 10.3390/cancers16081513.
Effect of Intermittent Fasting on Cardiometabolic Health in the Chinese Population: A Meta-Analysis of Randomized Controlled Trials.
Cheung K, Chan V, Chan S, Wong M, Chung G, Cheng W
Nutrients. 2024; 16(3).
PMID: 38337642
PMC: 10857210.
DOI: 10.3390/nu16030357.
Effect of Intermittent Fasting on Lipid Profile, Anthropometric and Hepatic Markers in Non-Alcoholic Fatty Liver Disease (NAFLD): A Systematic Review.
Castillo M, Salgado-Canales D, Arrese M, Barrera F, Mikhailidis D
Curr Vasc Pharmacol. 2024; 22(3):187-202.
PMID: 38321893
DOI: 10.2174/0115701611285401240110074530.
Ramadan fasting model exerts hepatoprotective, anti-obesity, and anti-hyperlipidemic effects in an experimentally-induced nonalcoholic fatty liver in rats.
Alasmari A, Al-Khalifah A, BaHammam A, Alshiban N, Almnaizel A, Alodah H
Saudi J Gastroenterol. 2024; 30(1):53-62.
PMID: 38192177
PMC: 10852143.
DOI: 10.4103/sjg.sjg_204_23.
The effects of intermittent fasting diet in comparison with low-calorie diet on lipid profile, glycemic status, and liver fibrosis in patients with non-alcoholic fatty liver (NAFLD): a study protocol for a randomized controlled clinical trial.
Karimi M, Mofidi Nejad M, Akhgarjand C, Sohrabpour A, Poustchi H, Imani H
BMC Nutr. 2023; 9(1):145.
PMID: 38066628
PMC: 10704665.
DOI: 10.1186/s40795-023-00794-x.
Metabolic-Dysfunction-Associated Steatotic Liver Disease-Its Pathophysiology, Association with Atherosclerosis and Cardiovascular Disease, and Treatments.
Yanai H, Adachi H, Hakoshima M, Iida S, Katsuyama H
Int J Mol Sci. 2023; 24(20).
PMID: 37895151
PMC: 10607514.
DOI: 10.3390/ijms242015473.
The Impact of Intermittent Fasting on Non-Alcoholic Fatty Liver Disease in Older Adults: A Review of Clinicaltrials.gov Registry.
Alorfi N, Ashour A
Diabetes Metab Syndr Obes. 2023; 16:3115-3121.
PMID: 37822800
PMC: 10564080.
DOI: 10.2147/DMSO.S430740.
Metabolic health phenotype better predicts subclinical atherosclerosis than body mass index-based obesity phenotype in the non-alcoholic fatty liver disease population.
Wang Y, Yuan T, Deng S, Zhu X, Deng Y, Liu X
Front Nutr. 2023; 10:1104859.
PMID: 37794971
PMC: 10546180.
DOI: 10.3389/fnut.2023.1104859.
Effects of Ramadan Intermittent Fasting on the Severity of β-Thalassemia Major Patients.
Ibraheem A
Cureus. 2023; 15(3):e36735.
PMID: 37123750
PMC: 10139676.
DOI: 10.7759/cureus.36735.
Different Dietary Approaches, Non-Alcoholic Fatty Liver Disease and Cardiovascular Disease: A Literature Review.
Torres-Pena J, Arenas-de Larriva A, Alcala-Diaz J, Lopez-Miranda J, Delgado-Lista J
Nutrients. 2023; 15(6).
PMID: 36986213
PMC: 10058124.
DOI: 10.3390/nu15061483.
The effect of intermittent fasting on the clinical and hematological parameters of patients with sickle cell disease: A preliminary study.
Ahmed K, Abdu Y, Khasawneh S, Shukri A, Adam E, Mustafa S
Front Med (Lausanne). 2023; 10:1097466.
PMID: 36895718
PMC: 9989014.
DOI: 10.3389/fmed.2023.1097466.
Management of metabolic-associated fatty liver disease: The diabetology perspective.
Jeeyavudeen M, Khan S, Fouda S, Pappachan J
World J Gastroenterol. 2023; 29(1):126-143.
PMID: 36683717
PMC: 9850951.
DOI: 10.3748/wjg.v29.i1.126.
Metabolic Role of Autophagy in the Pathogenesis and Development of NAFLD.
An L, Wirth U, Koch D, Schirren M, Drefs M, Koliogiannis D
Metabolites. 2023; 13(1).
PMID: 36677026
PMC: 9864958.
DOI: 10.3390/metabo13010101.
Role of Circadian Clock on the Pathogenesis and Lifestyle Management in Non-Alcoholic Fatty Liver Disease.
Perez-Diaz-Del-Campo N, Castelnuovo G, Caviglia G, Armandi A, Rosso C, Bugianesi E
Nutrients. 2022; 14(23).
PMID: 36501083
PMC: 9736115.
DOI: 10.3390/nu14235053.